Tumiclas, Alin .

HRN: 12-33-36  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2024
CEFUROXIME 500MG (TAB)
09/01/2024
09/07/2024
ORAL
500mg
BID
S/P Cesarean Section
Waiting Final Action 
09/01/2024
MUPIROCIN 2%, 15G (TUBE)
09/01/2024
09/07/2024
TOPICAL
12%, 15g
BID
S/P Cesarean Section
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: